Annual Cash & Cash Equivalents
$230.78 M
+$145.52 M+170.68%
December 31, 2023
Summary
- As of February 7, 2025, DAWN annual cash & cash equivalents is $230.78 million, with the most recent change of +$145.52 million (+170.68%) on December 31, 2023.
- During the last 3 years, DAWN annual cash & cash equivalents has risen by +$187.06 million (+427.77%).
- DAWN annual cash & cash equivalents is now -18.83% below its all-time high of $284.31 million, reached on December 31, 2021.
Performance
DAWN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$422.76 M
+$183.15 M+76.43%
September 30, 2024
Summary
- As of February 7, 2025, DAWN quarterly cash and cash equivalents is $422.76 million, with the most recent change of +$183.15 million (+76.43%) on September 30, 2024.
- Over the past year, DAWN quarterly cash and cash equivalents has increased by +$191.98 million (+83.19%).
- DAWN quarterly cash and cash equivalents is now at all-time high.
Performance
DAWN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DAWN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +170.7% | +83.2% |
| 3 y3 years | +427.8% | +249.8% |
| 5 y5 years | +744.4% | +249.8% |
DAWN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.8% | +170.7% | at high | +758.1% |
| 5 y | 5-year | -18.8% | +744.4% | at high | +866.8% |
| alltime | all time | -18.8% | +744.4% | at high | +866.8% |
Day One Biopharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $422.76 M(+76.4%) |
| Jun 2024 | - | $239.62 M(-11.4%) |
| Mar 2024 | - | $270.39 M(+17.2%) |
| Dec 2023 | $230.78 M(+170.7%) | $230.78 M(-4.3%) |
| Sep 2023 | - | $241.18 M(+27.5%) |
| Jun 2023 | - | $189.21 M(+284.0%) |
| Mar 2023 | - | $49.27 M(-42.2%) |
| Dec 2022 | $85.26 M | $85.26 M(-29.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $120.86 M(-68.9%) |
| Jun 2022 | - | $388.88 M(+48.0%) |
| Mar 2022 | - | $262.73 M(-7.6%) |
| Dec 2021 | $284.31 M(+550.2%) | $284.31 M(-4.3%) |
| Sep 2021 | - | $297.16 M(-4.1%) |
| Jun 2021 | - | $310.00 M(+100.2%) |
| Mar 2021 | - | $154.87 M(+254.2%) |
| Dec 2020 | $43.73 M(+60.0%) | $43.73 M |
| Dec 2019 | $27.33 M | - |
FAQ
- What is Day One Biopharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Day One Biopharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Day One Biopharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of DAWN is $230.78 M
What is the all time high annual cash & cash equivalents for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual cash & cash equivalents is $284.31 M
What is Day One Biopharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, DAWN annual cash & cash equivalents has changed by +$145.52 M (+170.68%)
What is Day One Biopharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of DAWN is $422.76 M
What is the all time high quarterly cash and cash equivalents for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly cash and cash equivalents is $422.76 M
What is Day One Biopharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, DAWN quarterly cash and cash equivalents has changed by +$191.98 M (+83.19%)